About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Vagal Nerve Stimulation Market Size, Top Share, Forecast to 2031
Vagal Nerve Stimulation Market

Vagal Nerve Stimulation Market Size, Share & Trends Analysis Report By Product Type (Implanted VNS Devices, External VNS Devices), By Applications (Depression, Epilepsy), By End-User (Hospitals, Ambulatory Surgical Centers) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI54491DR
Last Updated : November 26, 2024
Author : Debashree Bora
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Vagal Nerve Stimulation Market Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Implanted VNS Devices
        1. By Value
      3. External VNS Devices
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Depression
        1. By Value
      3. Epilepsy
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Implanted VNS Devices
        1. By Value
      3. External VNS Devices
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Depression
        1. By Value
      3. Epilepsy
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
    5. U.S.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Implanted VNS Devices
          1. By Value
        3. External VNS Devices
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Depression
          1. By Value
        3. Epilepsy
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
    6. Canada
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Implanted VNS Devices
        1. By Value
      3. External VNS Devices
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Depression
        1. By Value
      3. Epilepsy
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
    5. U.K.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Implanted VNS Devices
          1. By Value
        3. External VNS Devices
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Depression
          1. By Value
        3. Epilepsy
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Implanted VNS Devices
        1. By Value
      3. External VNS Devices
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Depression
        1. By Value
      3. Epilepsy
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
    5. China
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Implanted VNS Devices
          1. By Value
        3. External VNS Devices
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Depression
          1. By Value
        3. Epilepsy
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Implanted VNS Devices
        1. By Value
      3. External VNS Devices
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Depression
        1. By Value
      3. Epilepsy
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
    5. UAE
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Implanted VNS Devices
          1. By Value
        3. External VNS Devices
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Depression
          1. By Value
        3. Epilepsy
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Implanted VNS Devices
        1. By Value
      3. External VNS Devices
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Depression
        1. By Value
      3. Epilepsy
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Ambulatory Surgical Centers
        1. By Value
    5. Brazil
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Implanted VNS Devices
          1. By Value
        3. External VNS Devices
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Depression
          1. By Value
        3. Epilepsy
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Ambulatory Surgical Centers
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Vagal Nerve Stimulation Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Livanova Plc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Reshape Lifesciences Inc
    3. Electrocore Medical Llc
    4. Boston Scientific Corporation
    5. Imthera Medical Inc
    6. Inspire Medical Systems Inc
    7. Parasym Ltd
    8. Innovative Health Solutions Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Market Overview The global spinal cord stimulation market size was valued at USD 2.1 billion in 2020 and is projected to reach USD 4.28 billion by 2030 at a CAGR of 8.26% from 2022 to 2030. The spinal cord stimulator (SCS), also called the dor
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.